ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review

May 14, 1993

NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice

May 8, 1981

Younger Patients, More Advanced Stages, More Likely To Die From Breast Cancer

September 24, 2004

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007

First Report On Carcinogens Now Avaiable

October 3, 1980

Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future

March 1, 1996